patiromer (veltassa) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB

Active Ingredient History

NOW
  • Now
Patiromer, sold under the brand name Veltassa, is a medication used to treat high blood potassium. It is taken by mouth. It works by binding potassium in the gut.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$19.2603 - $38.4288
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

patiromer | patiromer calcium | patiromer fos | patiromer glucitol calcium | patiromer sorbitex calcium | rly5016 | rly 5016 | rly-5016 | rly5016s | veltassa

Organizations (24)

Research & Development (24)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (9)

Approved Indications (1)


 

Hyperkalemia

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Chronic Kidney Disease-Mineral and Bone Disorder (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Drugs, Investigational (Phase 4)

Heart Failure (Phase 4)

Hyperkalemia (Phase 4)

Hypertension (Phase 2)

Kidney Failure, Chronic (Phase 4)

Kidney Transplantation (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial Organizations: 24

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue